79 related articles for article (PubMed ID: 26837991)
1. F-18 FDG PET/CT in restaging of a rare case of malignant cystosarcoma phylloides.
Manohar K; Mittal BR; Kashyap R; Bhattacharya A; Sharma SC
Indian J Cancer; 2015; 52(1):105. PubMed ID: 26837991
[No Abstract] [Full Text] [Related]
2. A pulmonary metastasis of a cystosarcoma phyllodes of the breast detected by 18F-FDG PET/CT.
Treglia G; Muoio B; Caldarella C; Parapatt GK
Clin Nucl Med; 2014 Mar; 39(3):e233-5. PubMed ID: 23603592
[TBL] [Abstract][Full Text] [Related]
3. Utility of (18)F-FDG PET-CT in staging and restaging of patients with malignant salivary gland tumours: a single-institutional experience.
Sharma P; Jain TK; Singh H; Suman SK; Faizi NA; Kumar R; Bal C; Malhotra A; Kumar R
Nucl Med Commun; 2013 Mar; 34(3):211-9. PubMed ID: 23353886
[TBL] [Abstract][Full Text] [Related]
4. Synchronize primary breast osteosarcoma and contralateral benign cystosarcoma phylloides: radiologic and pathologic imaging.
Uner A; Ozturk B; Benekli M; Coskun U; Kocak S; Kaya AO; Unsal D; Erekul S; Yaman E; Yildiz R; Buyukberber S
Breast J; 2008; 14(1):109-10. PubMed ID: 18186876
[No Abstract] [Full Text] [Related]
5. [Malignant phyllodes tumor of the breast with lymph node metastases shown by FDG PET-CT].
Santiago Chinchilla A; Ramos Font C; Custodio Rebollo Aguirre A; Navarro-Pelayo Láinez M; Palacios Gerona H; Llamas Elvira JM
Rev Esp Med Nucl; 2010; 29(6):314-5. PubMed ID: 20692076
[No Abstract] [Full Text] [Related]
6. ¹⁸F-Fluorodeoxyglucose positron emission tomography/computed tomography finds answers in cancer patients with increasing tumor markers and negative or equivocal conventional imaging modalities.
Salem SS; Shahin MA
Nucl Med Commun; 2012 Mar; 33(3):313-21. PubMed ID: 22237387
[TBL] [Abstract][Full Text] [Related]
7. Rare Case of Phyllodes Tumor of Breast with Cardiac and Pancreatic Metastases: Findings on
Singh P; Parida GK; Singhal T; Kumar P; Bishnoi K; Agrawal K
J Nucl Med Technol; 2023 Jun; 51(2):156-157. PubMed ID: 36750379
[TBL] [Abstract][Full Text] [Related]
8. Clinical utility of F-18 FDG PET/CT in recurrent breast carcinoma.
Manohar K; Mittal BR; Senthil R; Kashyap R; Bhattacharya A; Singh G
Nucl Med Commun; 2012 Jun; 33(6):591-6. PubMed ID: 22334135
[TBL] [Abstract][Full Text] [Related]
9. 18F-FDG PET/CT in a rare malignant extraskeletal osteosarcoma.
Cao Q; Lu M; Huebner T; Dilsizian V; Chen W
Clin Nucl Med; 2013 Sep; 38(9):e367-9. PubMed ID: 23856822
[TBL] [Abstract][Full Text] [Related]
10. ¹⁸F-FDG-PET/CT in staging, restaging, and treatment response assessment of male breast cancer.
Groheux D; Hindié E; Marty M; Espié M; Rubello D; Vercellino L; Bousquet G; Ohnona J; Toubert ME; Merlet P; Misset JL
Eur J Radiol; 2014 Oct; 83(10):1925-33. PubMed ID: 24985086
[TBL] [Abstract][Full Text] [Related]
11. Cystosarcoma phylloides: calcified pulmonary metastases detected by computed tomography.
Samuels T; Kerenyi N; Hamilton P
Can Assoc Radiol J; 1990 Aug; 41(4):217-8. PubMed ID: 2169970
[TBL] [Abstract][Full Text] [Related]
12. [Cystosarcoma phyllodes].
D'Orto S; Bonomi G; Terraroli P; Galbussera M; Avogadri C; Peta C
Minerva Ginecol; 1991 Oct; 43(10):481-3. PubMed ID: 1662789
[TBL] [Abstract][Full Text] [Related]
13. ¹¹C-methionine and ¹⁸F-fluorodeoxyglucose positron emission tomography/CT in the evaluation of patients with suspected primary and residual/recurrent gliomas.
Li DL; Xu YK; Wang QS; Wu HB; Li HS
Chin Med J (Engl); 2012 Jan; 125(1):91-6. PubMed ID: 22340472
[TBL] [Abstract][Full Text] [Related]
14. Primary rhabdomyosarcoma of pulmonary artery: 18F-FDG PET/CT for detecting recurrence in a rare tumor.
Suman KC; Sharma P; Singh H; Bal C; Kumar R
Clin Nucl Med; 2013 Mar; 38(3):e155-6. PubMed ID: 23412603
[TBL] [Abstract][Full Text] [Related]
15. [Diagnostic value of (18)F-FDG PET/CT imaging plus serum tumor marker assays for pulmonary lesions and clinical significance of SUVmax].
Zhang TM; Zhang LM; Liu Y; Zhang ZF; Wang CL
Zhonghua Yi Xue Za Zhi; 2012 Nov; 92(41):2901-4. PubMed ID: 23328236
[TBL] [Abstract][Full Text] [Related]
16. ¹⁸F-FDG PET/CT for Staging and Restaging of Breast Cancer.
Groheux D; Cochet A; Humbert O; Alberini JL; Hindié E; Mankoff D
J Nucl Med; 2016 Feb; 57 Suppl 1():17S-26S. PubMed ID: 26834096
[TBL] [Abstract][Full Text] [Related]
17. Utility of F-18 fluorodeoxyglucose posıtron emıssıon tomography/computed ın carcınoma of unknown primary.
Elboga U; Kervancioğlu S; Sahin E; Basibuyuk M; Celen YZ; Aktolun C
Int J Clin Exp Pathol; 2014; 7(12):8941-6. PubMed ID: 25674269
[TBL] [Abstract][Full Text] [Related]
18. Impact of ¹⁸F-FDG PET/CT for detecting recurrence of medullary thyroid carcinoma.
Ozkan E; Soydal C; Kucuk ON; Ibis E; Erbay G
Nucl Med Commun; 2011 Dec; 32(12):1162-8. PubMed ID: 21946617
[TBL] [Abstract][Full Text] [Related]
19. Guidelines for the role of FDG-PET/CT in lung cancer management.
Al-Jahdali H; Khan AN; Loutfi S; Al-Harbi AS
J Infect Public Health; 2012 Dec; 5 Suppl 1():S35-40. PubMed ID: 23244185
[TBL] [Abstract][Full Text] [Related]
20. Impact of (18) F-fluorodeoxyglucose (FDG)-positron-emission tomography/computed tomography (PET/CT) on management of patients with carcinoma invading bladder muscle.
Mertens LS; Fioole-Bruining A; Vegt E; Vogel WV; van Rhijn BW; Horenblas S
BJU Int; 2013 Oct; 112(6):729-34. PubMed ID: 23790129
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
